[1]
Traina, G. et al. 2021. Evaluation of safety and tolerability of a rush up-dosing allergen-specific immunotherapy with grass pollen, birch, hazel, and alder allergoid in children with allergic rhinoconjunctivitis, with or without asthma. Acta Biomedica Atenei Parmensis. 92, 1 (Feb. 2021), e2021037. DOI:https://doi.org/10.23750/abm.v92i1.9096.